Fatalities associated with clozapine-related constipation and bowel obstruction: A literature review and two case reports

Psychosomatics

Volumn 50, Issue 4, 2009, Pages 416-419

  Hibbard, Katharine R ^a   Propst, Arthur ^a   Frank, Daniel E ^a   Wyse, Jonathan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOCUSATE SODIUM; FLURAZEPAM; GLIBENCLAMIDE; GLYCEROL; ISPAGULA; LAMOTRIGINE; LEVOTHYROXINE; OXYBUTYNIN; PROCYCLIDINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACID ASPIRATION; ADULT; ARTICLE; BEDTIME DOSAGE; CAUSE OF DEATH; CLINICAL ARTICLE; COLON DILATATION; COLON PERFORATION; CONSTIPATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG MECHANISM; FECES IMPACTION; FEMALE; HEBEPHRENIA; HIGH FIBER DIET; HUMAN; HYPERSALIVATION; INTESTINE ISCHEMIA; INTESTINE NECROSIS; INTESTINE OBSTRUCTION; LUNG EDEMA; MALE; MORNING DOSAGE; MORTALITY; MULTIPLE ORGAN FAILURE; MYOCLONUS; NECROTIZING COLITIS; PNEUMONIA; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; SEPTIC SHOCK; VOMITING;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CONSTIPATION; DRUG THERAPY, COMBINATION; FLURAZEPAM; GABA MODULATORS; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL OBSTRUCTION; INTUBATION, GASTROINTESTINAL; MALE; MANDELIC ACIDS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PROCYCLIDINE; SCHIZOPHRENIA; THYROXINE; TRIAZINES;

EID: 69249154676     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.50.4.416     Document Type: Letter

References (16)

1. Stahl S: The Prescriber's Guide. Cambridge, UK, Cambridge University Press, 2005, p 95
2. Novartis Pharmaceuticals Canada Inc.: Clozaril Product Monograph. Revised, 2004
3. Liebermann JA, Safferman AZ, Pollack S, et al: Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 1994; 151:1744-1752 (Pubitemid 24370894)
4. Hayes G, Gibler B: Clozapine-induced constipation (letter). Am J Psychiatry 1995; 152:298
5. Drew L, Herdson P: Clozapine and constipation: a serious issue. Aust N Z J Psychiatry 1997; 31:149-150
6. Theret L, Germaine ML, Burde A: Current aspects of the use of clozapine in the Chalons-Sur-Marne Psychiatric Hospital: intestinal occlusion with clozapine (French). Ann Med Psychol (Paris) 1995; 153:474-477
7. Shammi CM, Remington G: Clozapine-induced necrotizing colitis (letter). J Clin Psychopharmacol 1997; 17:230-231
8. Levin TT, Barrett J, Mendelowitz A: Death from clozapine-induced constipation: case report and literature review. Psychosomatics 2002; 43:71-73 (Pubitemid 34214167)
9. Townsend G, Curtis D: Case report: rapidly fatal bowel ischaemia on clozapine treatment. BMC Psychiatry 2006; 6:43 (Pubitemid 44642546)
10. Rousseau A, Charbonneau M: Severe fecal impaction under clozapine, resulting in death. J AMPQ (Assoc des Médécins Psychiatres du Québec) 2007; 11:16-18
11. Meltzer H, Nash F: Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 1991; 43:587-604
12. Liaw CC, Wang CH, Chang HK, et al: Control of cisplatin-induced emesis with intravenous ondansetron plus intravenous dexamethasone: a crossover study of triple 8-mg dose of ondansetron. Am J Clin Oncol 2000; 23:253-257
13. Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132:397-414
14. Reinstein MJ, Sirotovskaya LA, Jones LE, et al: Effect of clozapine-quetiapine combination therapy on weight and glycaemic control. Clin Drug Invest 1999; 18:99-104
15. Brandt LJ, Prather CM, Quigley EM, et al: Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005; 100:S5-S21
16. Voderholzer WA, Schatke W, Muhldorfer BE, et al: Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997; 92:95-98 (Pubitemid 27027036)